Lates News

In the afternoon, the concept of innovative drugs continued to strengthen, with Hengrui Medicine hitting the limit up. Previously, Haisi Pharma, Lianhuan Pharma, and Asia-Pacific Pharma all hit the limit up, while Guangshengtang rose by more than 10%. Rejing Biotech, Worth Paying Attention To, Frontier Biotech, and Zejing Pharmaceutical were among the top gainers.